“Characterizing Deep Quality-of-Life Response in the TRuE-V1 TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s752. https://doi.org/10.25251/bpnxm492.